BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 34913073)

  • 1. HMGA2 promotes the migration and invasion of gallbladder cancer cells and HMGA2 knockdown inhibits angiogenesis via targeting VEGFA.
    Yan J; Dai P; Qin X; He Y; Zhang Y
    Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1 knockdown suppresses vasculogenic mimicry of non-small cell lung cancer by modulating ZEB1-triggered EMT.
    Li W; Wu J; Jia Q; Shi Y; Li F; Zhang L; Shi F; Wang X; Wu S
    BMC Cancer; 2024 May; 24(1):633. PubMed ID: 38783271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2.
    Jiang S; Liu X; Li D; Yan M; Ju C; Sun J; Jiang F
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818797587. PubMed ID: 30198403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXA2 suppresses gallbladder carcinoma cell migration, invasion, and epithelial-mesenchymal transition by targeting SERPINB5.
    Hong L; Chen M; Huang M; Chen W; Abudukeremu X; She F; Chen Y
    Environ Toxicol; 2024 Feb; 39(2):708-722. PubMed ID: 37665156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of HMGA2 in activating the IGFBP2 expression to promote angiogenesis and LUAD metastasis via the PI3K/AKT/VEGFA signaling pathway.
    Qian S; Wang F; Liao W; Liu J
    Neoplasma; 2024 Feb; 71(1):22-36. PubMed ID: 38506034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-299-3p inhibits cell proliferation, motility, invasion and angiogenesis via VEGFA in upper tract urothelial carcinoma.
    Wang CS; Lee YC; Jhan JH; Li WM; Chang LL; Huang AM; Lin HH; Wu YR; Hsu WC; Ke HL
    J Gene Med; 2024 Jan; 26(1):e3616. PubMed ID: 38049938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of HMGA2 on the biological characteristics and stemness acquisition of gastric cancer cells.
    Kong D; Zha L; Yao Y; Zhang Z; Gao J; Zhang R; Chen L; Wang Z
    Arab J Gastroenterol; 2024 May; 25(2):135-142. PubMed ID: 38378354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC02454 promotes thyroid carcinoma progression via upregulating HMGA2 through CREB1.
    Cao Y; Li J; Du Y; Sun Y; Liu L; Fang H; Liang Y; Mao S
    FASEB J; 2023 Dec; 37(12):e23288. PubMed ID: 37997502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SERPINB5 promotes colorectal cancer invasion and migration by promoting EMT and angiogenesis via the TNF-α/NF-κB pathway.
    Liu BX; Xie Y; Zhang J; Zeng S; Li J; Tao Q; Yang J; Chen Y; Zeng C
    Int Immunopharmacol; 2024 Apr; 131():111759. PubMed ID: 38460302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-myc Downstream-Regulated Gene 1 (NDRG1) Regulates Vascular Endothelial Growth Factor A (VEGFA) and Malignancies in Glioblastoma Multiforme (GBM).
    Zhang X; Chen Q; Li Y; Chen H; Jiang Q; Hu Q
    Biomed Res Int; 2022; 2022():3233004. PubMed ID: 35813230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DLGAP5 promotes gallbladder cancer migration and tumor-associated macrophage M2 polarization by activating cAMP.
    Huang J; Zheng M; Li Y; Xu D; Tian D
    Cancer Immunol Immunother; 2023 Oct; 72(10):3203-3216. PubMed ID: 37421434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated circRNA_CDKN1A promotes gallbladder cancer progression through activation of the NF-κB pathway.
    Hu B; Yang H; Wang Y; Cao Y; Zhou R; Yang D
    Cell Biochem Funct; 2024 Mar; 42(2):e3952. PubMed ID: 38343018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM21-mediated ubiquitylation of TAT suppresses liver metastasis in gallbladder cancer.
    Wu Z; Zhang J; Jia Z; Yang Z; Liu S; Wang H; Zhao C; Zhao J; Tang Q; Xiong Y; Yang Y; Zhang Y; Zhou Z; Yue J; Xiao F; Sun Q; Gong A; Yao W; Li H; Song X; Ye Y; Zhu Y; Dong P; Ma F; Wu X; Gong W
    Cancer Lett; 2024 Jun; 592():216923. PubMed ID: 38697462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor-related receptor γ uppresses hypoxia-induced angiogenesis by regulating VEGFA in endometrial cancer.
    Wang XX; Hua T; Wang HB
    Gynecol Endocrinol; 2023 Dec; 39(1):2264411. PubMed ID: 37859604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Reduction of PSMB4 in T24 and J82 Bladder Cancer Cells Inhibits the Angiogenesis and Migration of Endothelial Cells.
    Lin YH; Chen TM; Tsai YL; Tsai WC; Wang HH; Chen Y; Wu ST
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eukaryotic translation initiation factor 6 overexpression plays a major role in the translational control of gallbladder cancer.
    Golob-Schwarzl N; Wodlej C; Kleinegger F; Gogg-Kamerer M; Birkl-Toeglhofer AM; Petzold J; Aigelsreiter A; Thalhammer M; Park YN; Haybaeck J
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2699-2711. PubMed ID: 31586263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori-induced fibroblast-derived Serpin E1 promotes gastric cancer growth and peritoneal dissemination through p38 MAPK/VEGFA-mediated angiogenesis.
    Cheng W; Liao Y; Xie Y; Wang Q; Li L; Chen Y; Zhao Y; Zhou J
    Cancer Cell Int; 2023 Dec; 23(1):326. PubMed ID: 38104099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gli1-mediated tumor cell-derived bFGF promotes tumor angiogenesis and pericyte coverage in non-small cell lung cancer.
    Lei X; Li Z; Huang M; Huang L; Huang Y; Lv S; Zhang W; Chen Z; Ke Y; Li S; Chen J; Yang X; Deng Q; Liu J; Yu X
    J Exp Clin Cancer Res; 2024 Mar; 43(1):83. PubMed ID: 38493151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity.
    Kaur H; Hütt-Cabezas M; Weingart MF; Xu J; Kuwahara Y; Erdreich-Epstein A; Weissman BE; Eberhart CG; Raabe EH
    J Neuropathol Exp Neurol; 2015 Feb; 74(2):177-85. PubMed ID: 25575139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role and mechanism of HMGA2 in breast cancer.
    Ma Q; Ye S; Liu H; Zhao Y; Zhang W
    J Cancer Res Clin Oncol; 2024 May; 150(5):259. PubMed ID: 38753081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.